Revolade NZ CMI

Revolade NZ CMI revolade Eltrombopag is sold under the brand name Revolade outside the US and is marketed by Novartis It is a thrombopoietin receptor agonist It is taken by mouth revolade REVOLADE Page 2 2 Page 3 Your practical guide CONTENTS 4 Supporting your eltrombopag patients 6 What is eltrombopag? 8 Prescribing

revolade Revolade 50mg Tablet is used to treat low platelet count due to chronic immune thrombocytopenic purpura or chronic hepatitis C virus

revolade Revolade Active substance Eltrombopag Holder Novartis Status Closed Indication patients aged 1 year and above with primary immune thrombocytopenia Revolade 50mg Tablet is used to treat low platelet count due to chronic immune thrombocytopenic purpura or chronic hepatitis C virus